ADPT
Adaptive Biotechnologies Corporation
Stock
$28.35+0.98 (+3.58%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $308M | +23.0% |
| Gross profit | $233M | +22.1% |
| Operating income | −$37M | — |
| Net income | −$64M | — |
| EPS | −$0.42 | — |
| Free cash flow | −$24M | — |